retatrutide triple agonist clinical trials How Does Work? Doctor Explains Why It's So Effective Triple hormone receptor agonist retatrutide

Warning Research Use Only The GHK-Cu sold by Peptivia Lab is strictly intended for scientific laboratory research

But a large analysis of human head-and-neck cancer cases, conducted by the Mayo Clinic and published in 2025, debunked the link between GLP-1 drugs and thyroid cancer

doi: 10.1038/s41573-025-01145-0 30 GozzelinoRJeneyVSoaresMP

HNC, Head and neck cancer

The perils of surrogate endpoints

doi: 10.1074/jbc.M607955200 Summary Keywords ghrelin, ghrelin receptor (GHS-R1a), GPCR, structural biochemistry, orexigenic hormone Citation Shiimura Y, Kojima M and Sato T (2025) How the ghrelin receptor recognizes the acyl-modified orexigenic hormone